Literature DB >> 24432237

Cutaneous protothecosis in a patient with hypogammaglobulinemia.

Jason C Kwong1, Peter B Ward2, Paul D Johnson3.   

Abstract

Prototheca wickerhamii has been predominantly recognised as a pathogen in immunocompromised hosts with deficits in innate or cellular immunity. The role of specific immunoglobulin against Prototheca in host immunity is uncertain. We describe a case of persistent cutaneous protothecosis in a patient with hypogammaglobulinemia most likely due to common variable immunodeficiency, with clinical response to voriconazole.

Entities:  

Keywords:  Common variable immunodeficiency; Hypogammaglobulinemia; Prototheca; Protothecosis; Voriconazole

Year:  2013        PMID： 24432237      PMCID： PMC3885952          DOI： 10.1016/j.mmcr.2013.06.002

Source DB:  PubMed          Journal:  Med Mycol Case Rep        ISSN： 2211-7539


  10 in total

1.  Protothecosis successfully treated with amikacin combined with tetracyclines.

Authors:  J Zhao; W Liu; G Lv; Y Shen; S Wu
Journal:  Mycoses       Date:  2004-04       Impact factor: 4.377

Review 2.  Cutaneous protothecosis: two new cases in China and literature review.

Authors:  Sha Lu; Liyan Xi; Wei Qin; Yijin Luo; Changming Lu; Xiqing Li
Journal:  Int J Dermatol       Date:  2012-03       Impact factor: 2.736

3.  Establishment of a matrix-assisted laser desorption ionization time-of-flight mass spectrometry database for rapid identification of infectious achlorophyllous green micro-algae of the genus Prototheca.

Authors:  J Murugaiyan; J Ahrholdt; V Kowbel; U Roesler
Journal:  Clin Microbiol Infect       Date:  2011-07-22       Impact factor: 8.067

4.  Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies).

Authors:  M E Conley; L D Notarangelo; A Etzioni
Journal:  Clin Immunol       Date:  1999-12       Impact factor: 3.969

5.  In vitro activity of voriconazole against Prototheca wickerhamii: comparative evaluation of sensititre and NCCLS M27-A2 methods of detection.

Authors:  Maria José Linares; Francisco Solís; Manuel Casal
Journal:  J Clin Microbiol       Date:  2005-05       Impact factor: 5.948

6.  Phagocytosis and algicidal activity of human polymorphonuclear neutrophils against Prototheca wickerhamii.

Authors:  J P Phair; J E Williams; H P Bassaris; C R Zeiss; B A Morlock
Journal:  J Infect Dis       Date:  1981-07       Impact factor: 5.226

Review 7.  Protothecosis complicating prolonged endotracheal intubation: case report and literature review.

Authors:  V R Iacoviello; P C DeGirolami; J Lucarini; K Sutker; M E Williams; C A Wanke
Journal:  Clin Infect Dis       Date:  1992-12       Impact factor: 9.079

Review 8.  Human protothecosis.

Authors:  Cornelia Lass-Flörl; Astrid Mayr
Journal:  Clin Microbiol Rev       Date:  2007-04       Impact factor: 26.132

Review 9.  Protothecosis: report of a case with 20-year follow-up, and review of previously published cases.

Authors:  John R Todd; John W King; Arnold Oberle; Tadahiko Matsumoto; Yoshinobu Odaka; Marjorie Fowler; R Scott Pore; Tracy Allan Shahan; Lijia Yin; Irwan D Sanusi
Journal:  Med Mycol       Date:  2012-05-09       Impact factor: 4.076

10.  A rare case of prototheca algaemia in a patient with systemic lupus erythematosus and recent belimumab infusion.

Authors:  Carolina Mejia-Otero; Shelley Singh; Luis Arias Urdaneta; Carlos Sesin; Anindita Chakrabarti; Nanci Mae Miller; Claudio Tuda
Journal:  Case Reports Immunol       Date:  2012-11-21
  10 in total
  2 in total

1.  Cutaneous Protothecosis in a Patient with Chronic Lymphocytic Leukemia: A Case Report and Literature Review.

Authors:  Quynh-Giao Ly Nguyen; Ted Rosen
Journal:  J Fungi (Basel)       Date:  2015-01-14

2.  Multiple cutaneous infections caused by Prototheca wickerhamii.

Authors:  Feng Zhao; Miaode Chen; Ying Fu
Journal:  J Clin Lab Anal       Date:  2020-07-21       Impact factor: 2.352
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.